Biological Process
| aging | | IEA | Ensembl:ENSRNOP00000010939 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| cell adhesion | | IEA | Ensembl:ENSRNOP00000010939 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| cell adhesion | | IEA | InterPro:IPR015169 | 2290271 | GO_REF:0000002 | InterPro | GO_REF:0000002 |
| embryo development | | IEA | Ensembl:ENSRNOP00000010939 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| immune response | | TAS | | 2290271 | PMID:8502297 | PINC | PMID:8502297 |
| keratinocyte differentiation | | IEA | Ensembl:ENSMUSP00000020554 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| leukocyte migration | | IEA | Ensembl:ENSMUSP00000020554 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| positive regulation of leukocyte migration | | IEA | Ensembl:ENSRNOP00000010939 | 2290271 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| regulation of immune response | | TAS | | 2290271 | Reactome:REACT_11152 | Reactome | Reactome:REACT_11152 |
| signal transduction | | TAS | | 2290271 | PMID:8502297 | PINC | PMID:8502297 |
Cellular Component
| integral to membrane | | IEA | UniProtKB-KW:KW-0812 | 2290271 | GO_REF:0000037 | UniProtKB | GO_REF:0000037 |
| membrane | | IEA | InterPro:IPR015169 | 2290271 | GO_REF:0000002 | InterPro | GO_REF:0000002 |
| membrane | | TAS | | 2290271 | PMID:8502297 | PINC | PMID:8502297 |
| plasma membrane | | TAS | | 2290271 | Reactome:REACT_11199 | Reactome | Reactome:REACT_11199 |
| plasma membrane | | TAS | | 2290271 | Reactome:REACT_11230 | Reactome | Reactome:REACT_11230 |
| 1298476 | BP3_H | Blood pressure QTL 3 (human) | 2.4 | | Blood pressure | systolic | 19 | 38318 | 6113482 | Human |
| 1298499 | UAE1_H | Urinary albumin excretion QTL 1 (human) | 2.73 | .0009 | Urinary albumin excretion | urine albumin:creatinine ratio (ACR) | 19 | 1 | 16075900 | Human |
| 1300034 | BP50_H | Blood pressure QTL 50 (human) | 2.1 | .00094 | Blood pressure | systolic | 19 | 1 | 11244506 | Human |
| 1559347 | SCL92_H | Serum cholesterol level QTL 92 (human) | 2.15 | .0008 | Lipid level | LDL cholesterol | 19 | 1 | 25712901 | Human |
| 1559400 | SCL97_H | Serum cholesterol level QTL97 (human) | 3.89 | .00002 | Lipid level | total cholesterol | 19 | 1 | 19113369 | Human |
| 1559404 | SCL117_H | Serum cholesterol level QTL 117 (human) | 2.05 | | Lipid level | triglyceride-HDL ratio | 19 | 1 | 16140092 | Human |
| 1643248 | BW138_H | Body weight QTL 138 (human) | 1.47 | | Body weight | | 19 | 1 | 22804918 | Human |
| 2293449 | PRSTS270_H | Prostate tumor susceptibility QTL 270 (human) | | | Prostate tumor susceptibility | | 19 | 1 | 15567316 | Human |
| 2293432 | PRSTS269_H | Prostate tumor susceptibility QTL 269 (human) | | | Prostate tumor susceptibility | | 19 | 1 | 15567316 | Human |
| 2300113 | PRSTS337_H | Prostate tumor susceptibility QTL 337 (human) | | | Prostate tumor susceptibility | | 19 | 1 | 17392514 | Human |
| 2301145 | PRSTS371_H | Prostate tumor susceptibility QTL 371 (human) | 2.91 | .0001 | Prostate tumor susceptibility | | 19 | 1 | 31914947 | Human |
| 2301170 | PRSTS375_H | Prostate tumor susceptibility QTL 375 (human) | 1.87 | | Prostate tumor susceptibility | | 19 | 1 | 16314463 | Human |
| 2301168 | PRSTS378_H | Prostate tumor susceptibility QTL 378 (human) | 1.09 | | Prostate tumor susceptibility | | 19 | 1 | 16314463 | Human |
| 2301163 | PRSTS377_H | Prostate tumor susceptibility QTL 377 (human) | 1.59 | | Prostate tumor susceptibility | | 19 | 1 | 16314463 | Human |
| 2301152 | PRSTS373_H | Prostate tumor susceptibility QTL 373 (human) | 2.94 | | Prostate tumor susceptibility | | 19 | 1 | 16314463 | Human |
| 2314744 | GLUCO92_H | Glucose level QTL 92 (human) | .86 | .005 | Glucose level | non-insulin dependent | 19 | 1 | 22178483 | Human |
| 2316728 | GLUCO279_H | Glucose level QTL 279 (human) | 1.26 | .01358 | Glucose level | | 19 | 1 | 25712901 | Human |